Risk Stratification and Early Alerting Regarding COVID-19 Hospitalization

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Total Enrollment

8 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-02-08

Study Completion Date

2021-06-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this research is to remotely monitor individuals who have tested positive for COVID-19 to learn more about progression and recovery from the disease. Individuals who test positive for COVID-19 will wear the Current Health wearable device continuously and answer a brief series of questions on Current Health tablet daily for up to 30 days. The health data will be used to develop predictive models of hospitalization risk.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Monitoring Health Care Workers at Risk for COVID-19 Using Wearable Sensors and Smartphone Technology

NCT04756869

Covid19

COMPLETED

Natural History Study of COVID-19 Using Digital Wearables

NCT04927442

COVID-19 Virus Disease

COMPLETED

Continuous Wireless Monitoring of Vital Signs and Automated Alerts of Patient Deterioration in Patients Admitted With COVID-19 Infection

NCT04724681

Clinical Deterioration

TERMINATED NA

COVID-19 Risk Assessment for Hospitalization Outcomes and Epidemiology Efficacy

NCT04678193

Covid19

RECRUITING

Remote Monitoring of COVID-19 Positive Outpatients

NCT04853108

Covid19

TERMINATED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Covid19

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

COVID19+

Current Health

Intervention Type DEVICE

wearable device and tablet used to collect health measures at home

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Current Health

wearable device and tablet used to collect health measures at home

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Living in the United States (contiguous states)
* Aged 21 years or older
* Able to provide documentation of +Polymerase Chain Reaction (PCR) or +antigen test for COVID-19 within the past 48 hours
* Self-reports that comfortable and willing to wear the wearable device and interact with a tablet-based interface daily
* Able to provide a next of kin/designated person who can be contacted in the event of hospitalization for follow up.

Exclusion Criteria

* Under the age of 21
* Received a positive test result more than 48 hours prior to contacting study staff or has a pending test for COVID-19
* Cannot confirm a PCR or antigen positive test for COVID-19
* Is unable to read English
* Is unwilling to wear the device 24 hours/day except for showering/bathing or interact with a tablet-based interface for daily questionnaire
* Is unwilling or unable to provide baseline data required for entry into the study
* Is unable to provide a next of kin/designated person who can be contacted in the event of hospitalization for follow-up
* Heavy tattooing on both upper arms
* Known atrial fibrillation (permanent or paroxysmal)
* Has taken/is taking part in a COVID-19 vaccine or treatment trial

Minimum Eligible Age

21 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No